New strategy to strengthen WA's clinical trials networkFocus on improving health outcomes and attracting global investment to WALaunched at Future ...

BioCardia, Inc. ( NASDAQ: BCDA) Q1 2025 Earnings Conference Call May 14, 2025, 16:30 PM ET Peter Altman - President and CEO David McClung - CFO Miranda Peto - IR Joe Pantginis - H.C. Wainwright Laura ...

Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET. Company Participants. Jaclyn Jaffe - Senior Director, Corporate Operations Clau ...

Live webcasts of the presentations will be available on the News & Events – Events page of Jasper's Investor Relations website. An archived replay of each presentation will be available on Jasper's ...

Inspired by the world's great Lego Masters, Arovella is taking a brick-by-brick approach to building its unique cancer ...

The Phase 2 study of oral, once-daily mavorixafor was a six-month, open-label clinical trial that enrolled a total of 23 ...

The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...

A recent analysis reveals that ellipsoidal zone-retinal pigment epithelial thickness predicts future visual loss in ...

A new all-in-one pulsed field ablation catheter system demonstrated durable pulmonary vein isolation and a promising safety ...

The head of the FDA reiterated that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters.

ROCKVILLE, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage ...

VCN-01 Achieves Primary Efficacy and Safety Endpoints for Pancreatic Ductal Adenocarcinoma in VIRAGE Phase 2b Clinical Trial - - Closed a public offering on May 8, 2025, raising the Company's cash ...